Topic
Disclosure
833 published works
Cleary Enforcement Watch
SEC Sanctions ADT Over Non-GAAP Financial Measures in Earnings Releases
By Leslie N. Silverman, Nick Grabar, Matthew C. Solomon, Alex Janghorbani
On December 26, 2018, the SEC announced settled charges against ADT Inc. after finding that ADT, in two earnings releases, gave undue emphasis to non-GAAP adjusted EBITDA figures because they…
UK Finance Disputes and Regulatory Investigations Blog
New Disclosure Pilot Scheme – Now In Force
By Chris Webber, Katherine Wakeham
Think of a fairly common situation; you receive an email from a third party with three colleagues in copy, you forward this email to your colleagues with comments, one responds…
EvidenceProf Blog
Adam Gershowitz Posts “The Challenge of Convincing Ethical Prosecutors That Their Profession Has a Brady Problem” on SSRN
By Colin Miller
Adam Gershowitz (William & Mary) has posted "The Challenge of Convincing Ethical Prosecutors That Their Profession Has a Brady Problem" (Ohio State Journal of Criminal Law) on SSRN.Here is the…
The Securities Edge
Ho, Ho, Uh-Oh: The SEC continues to focus on non-GAAP disclosures
Lest you think that the SEC’s focus on the use of non-GAAP financial metrics is so, well, 2018, think again. On December 26, the SEC issued a cease-and-desist order against…
Free Writings + Perspectives
SEC Adopts Dodd-Frank Hedging Disclosure Rule
By Laura D. Richman, David S. Bakst, Michael L. Hermsen
On December 18, 2018, the US Securities and Exchange Commission adopted a final rule requiring companies to disclose their hedging policies and practices for employees, officers and directors. This Legal…
The D&O Diary
Guest Post: Five Hidden Takeaways from the Khaled and Mayweather SEC Orders
[caption id="attachment_16885" align="alignleft" width="239"] John Reed Stark[/caption] On November 29, 2018, the SEC announced that it had settled charges with boxer Floyd Mayweather Jr. and music producer DJ Khaled for…
UK Finance Disputes and Regulatory Investigations Blog
Courts prepared to scrutinise and limit Norwich Pharmacal Orders
A Norwich Pharmacal Order ("NPO") forces a third party to disclose documents or information to an applicant. These Court orders are typically used to identify a proper defendant to a claim or to…
The SEC Institute Blog
Another MD&A Known Trend Disclosure and Materiality Lesson
In our workshop discussions dealing with MD&A the disclosure of “known trends” is always a complex topic. The idea of disclosing something that isn’t hurting your business currently but might…
The SEC Institute Blog
How to Pull the SEC’s Disclosure Update and Simplification Details All Together?
Over the last several weeks we have done a series of blog posts discussing changes from the SEC’s Disclosure Update and Simplification Final Rule on individual Form 10-K and 10-Q items.…
Cleary M&A and Corporate Governance Watch
Delaware Decision Provides Further Lessons for Directors, Activist Investors, and Financial Advisors in Negotiating Mergers
By Meredith E. Kotler, Roger A. Cooper, Mark E. McDonald, Kal Blassberger
The Delaware Court of Chancery yesterday found an activist investor aided and abetted a target board’s breaches of fiduciary duty, most significantly by concealing from the target board (and from…